Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: Evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2)

Clinical and Experimental Immunology

Volumn 109, Issue 3, 1997, Pages 495-500

  Kemp, E H ^a   Gawkrodger, D J ^a   Watson, P F ^a   Weetman, A P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Autoantigen; Autoimmunity; Tyrosinase; Tyrosinase related protein 2; Vitiligo

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; MONOPHENOL MONOOXYGENASE;

ADULT; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CROSS REACTION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMORAL IMMUNITY; HYPOTHYROIDISM; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VITILIGO;

EID: 0030770262     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4781381.x     Document Type: Article

References (17)

1. Harzoulis P, Kanakoud-Tsakalidis F, Uyzantiadis A. Autoimmunity and vitiligo. Arch Dermatol 1970; 114:1554-60.
2. Cui J, Harning R, Henn M, Bystryn JC. Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 1992; 98:162-5.
3. Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97:1078-80.
4. Naughton GK, Reggiardo D, Bystryn JC. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 1986; 15:978-81.
5. Norris DA, Kissinger RM, Naughton Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity (ADDC). J Invest Dermatol 1988; 90:783-9.
6. Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrund B, Yecheskel G. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 1996; 105:84-88.
7. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N. The role of lyrosinase in autoimmune vitiligo. Lancet 1994; 344:1049-52.
8. 35S-labelled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol 1997, in press.
9. Palumbo A, Solano F, Misuraca G, Aroca P, Garcia-Borron JC, Lozano JA, Prota G. Comparative action of dopachrome tautomerase and metal ions on the rearrangement of dopachrome. Biochim Biophys Acta 1991; 1115:1-5.
10. Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun 1989; 164:990-6.
11. Yokoyama K, Suzuki H, Yasumoto K, Tomita Y, Shibahara S. Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta 1994; 1217:317-21.
12. Falorni A, Grubin CE, Takei I et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr, 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19:113-25.
13. Falorni A, Nikoshokov A, Laureti S et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 1995; 80:2752-5.
14. Peterson P, Perheentupa J, Krohn KJE. Detection of candidal antigens in autoimmune polyglandular syndrome type I. Clin Diag Lab Immunol 1996; 3:290-4.
15. Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ. A second tyrosinase-related protein, TRP2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 1992; 11:519-26.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.